Centauri Health Solutions Buys QHIN MedAllies
Centauri Health Solutions, a Phoenix-based health information technology company, has acquired MedAllies, a New York-based qualified health information network (QHIN) under the TEFCA framework.
Founded in 2001, MedAllies launched the Hudson Valley Health Information Exchange in 2002. Today MedAllies provides interoperability services to more than 1,000 hospitals/health systems, 5,000 ambulatory organizations, and 125,000 healthcare providers.
In late 2023, MedAllies was awarded designation as a QHIN under the Trusted Exchange Framework and Common Agreement (TEFCA ). QHINs connect directly to each other to ensure interoperability between the networks they represent, enabling healthcare stakeholders to securely and reliably share accurate patient data, driving more informed patient-care decisions.
Centauri offers solutions to health systems and health plans for various healthcare programs including Medicare, Medicaid, commercial and Exchange. It addresses issues such as uncompensated care in health systems; risk-adjusted revenue for specialized populations; and enhances access to and quality of care measurement. The company has 1,500 employees nationwide and was been listed on the Inc. 5000 from 2019-2022.
“Centauri is the perfect partner for MedAllies. Our shared vision for interoperability and bi-directional exchange is essential to advancing healthcare,” said John Blair, M.D., CEO of MedAllies, in a statement. “We are excited to offer our clients the broadest clinical exchange network to support mission critical use cases.”
“The addition of MedAllies strengthens our commitment to intelligently deliver clinical data solutions in a manner and form that facilitates value creation and empowers shared risk initiatives,” said Mike McNelis, Centauri co-founder and CEO, in a statement. “Connecting the MedAllies HISP and best-in-class Care Enabled Network/QHIN with Centauri’s network and AI solutions offers significant value to all our clients.”
The acquisition was supported by Centauri’s lead investor, Abry Partners, along with Silversmith Capital Partners and SV Health Investors.
